NRx Pharmaceuticals

medicine pills
Biotech

NRx keeps antidepressant's blockbuster hopes alive despite flop

NRx's oral antidepressant has failed to reach statistical significance reducing depression severity in a phase 2/3 trial.
Gabrielle Masson Apr 30, 2024 11:16am
MA

Alvogen snags NRx's bipolar depression drug in $330M deal

Jun 7, 2023 6:30am
picture of a paraglider

Agios replaces CEO after recent FDA nod—Chutes & Ladders

Jul 15, 2022 9:30am
FDA Building

Déjà vu: FDA rejects NRx filing for emergency use in COVID-19

Jul 1, 2022 8:50am
visual of a parachute

Forte taps new exec amid shareholder dissent—Chutes & Ladders

Jun 10, 2022 9:30am
Concept of SARS-CoV-2 or COVID-19

NRx tanks as peptide fails NIH trial in severe COVID-19 patients

May 26, 2022 7:50am